Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Triazole-resistant Aspergillus fumigatus in the Netherlands between 1994 and 2022: a genomic and phenotypic study

15 Jul 2025

Abstract excerpt

Background Aspergillus fumigatus is the main cause of invasive aspergillosis and triazole antifungals are the primary treatment option. The effectiveness of triazole therapy is hampered by the emergence of resistance, mainly caused by mutations in the cyp51A gene and a tandem repeat (TR) of 34 bases (TR 34 /Leu98His) and 46 bases (TR 46 /Tyr121Phe/Thr289Ala) in the promoter region, which correspond with signature...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Nail Diseases and Treatments
Share to Ocular Infections and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40651492
DOI: 10.1016/j.lanmic.2025.101114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Triazole-resistant Aspergillus fumigatus in the Netherlands between 1994 and 2022: a genomic and phenotypic studyPMID 40651492Read ↗

Prevalence of cyp51A variants in a US collection of Aspergillus fumigatus clinical isolates and comparative analysis of their contribution to triazole antifungal resistance.Semantic proximity Read ↗

Genome-Wide Association Analysis for Triazole Resistance in Aspergillus fumigatusSemantic proximity Read ↗

Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutationsSemantic proximity Read ↗

Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China.Semantic proximity Read ↗

Triazole resistance surveillance in Aspergillus fumigatus.Semantic proximity Read ↗

Development and validation of next-generation sequencing-based clinical test for triazole resistance prediction in Aspergillus fumigatus.Semantic proximity Read ↗

Azole Resistance and cyp51A Mutation of Aspergillus fumigatus in a Tertiary Referral Hospital in TaiwanSemantic proximity Read ↗

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.Semantic proximity Read ↗

Widely dispersed clonal expansion of multi-fungicide-resistant Aspergillus fumigatus limits genomic epidemiology prospects.Semantic proximity Read ↗

High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?Semantic proximity Read ↗

Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in AsiaSemantic proximity Read ↗

Moving beyond multi-triazole to multi-fungicide resistance: Broader selection of drug resistance in the human fungal pathogen Aspergillus fumigatusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.